MACRO selected by the Mahidol Oxford Tropical Medicine Research Unit

InferMed today announced that the Mahidol Oxford Tropical Medicine Research Unit (MORU), headquartered in Bangkok, Thailand, has chosen MACRO as the EDC system for running its programme of commercial and academic trials.

 

InferMed today announced that the Mahidol Oxford Tropical Medicine Research Unit (MORU), headquartered in Bangkok, Thailand, has chosen MACRO as the EDC system for running its programme of commercial and academic trials.

MORU, with the generous support of the Wellcome Trust, has been studying and combating tropical diseases since 1979, and is uniquely placed to study some of the most challenging diseases affecting people in the developing world.  The unit runs mainly multi-centre trials that include many sites in the developing world in locations such as Bangladesh, Cambodia, Thailand and the Democratic Republic of Congo.

A video covering MORU’s important work can be seen here. The video was filmed at MORU in Bangkok and in the Mae Sot area at Shoklo Medical Research Unit (SMRU), Mae La Refugee Camp and the Wang Pa Free Clinic and shows some of the people and beneficiaries of MORU and SMRU's activities.

The Head of MORU’s Clinical Trials Support Group (CTSG), Dr Phaik Yeong Cheah, commented, “MORU required an affordable, fit-for-purpose and GCP-compliant EDC system that could be used for our multinational, multi-centre clinical trials programme and we identified MACRO as the ideal solution for our needs. Following MACRO training in Bangkok and the use of the system on some smaller studies, the unit will roll out MACRO to the larger study programme.”

Duane Lawrence, CEO of InferMed added, “It is a very sad fact that tropical infectious diseases remain a major cause of hardship and suffering for millions of people in the developing world. We admire the vital work that the Mahidol Oxford Tropical Medicine Research Unit is carrying out in its fight to reduce the human disease burden in the developing world, and we look forward to supporting the unit in its work and to seeing MACRO used in trials that can make such a difference to the quality of life for those that are suffering.”

The Mahidol Oxford Tropical Medicine Research Unit

The Mahidol Oxford Tropical Medicine Research Unit (MORU) aims to fight infectious tropical diseases affecting rural communities in Asia and elsewhere in the developing world. They develop effective and practical means of diagnosing and treating Malaria and other neglected diseases such as Typhus, Melioidosis, and Leptospirosis.

MORU is a collaboration between Mahidol University and the University of Oxford and was established with the Wellcome Trust in 1979. Their main office and laboratories are located within the Faculty of Tropical Medicine at Mahidol University in Bangkok, Thailand. They have study sites and collaborations across Thailand and in other parts of the developing world including Laos, Bangladesh, India, Cambodia, Tanzania, Ghana, and Democratic Republic of Congo.

MORU was established and is supported with significant funding from the Wellcome Trust, though they also receive funding from other trusts and foundations, governments, and multi-national donors.